Santiago Lozano-Calderon, MD, PhD
Santiago Lozano-Calderon, MD, PhD
Orthopaedic Oncology Surgeon
Assistant Professor of Orthopaedic Surgery, Harvard Medical School
Boston, MAPhone: 617-643-4947
About Santiago Lozano-Calderon, MD, PhD
Dr. Santiago Lozano specializes in the evaluation and treatment of primary benign and malignant tumors of bone and soft tissue, as well as metastatic bone disease. His practice involves clinical research evaluating treatment and outcomes in oncology patients.
Dr. Lozano is a board-certified orthopaedic oncology surgeon. He earned his MD from Pontificia Universidad Javeriana Medical School in Bogota, Colombia.
Following his MD, he earned his PhD from the University of Amsterdam in the Netherlands. He conducted his PhD thesis research with Dr. Jesse Jupiter and Dr. David Ring at Massachusetts General Hospital. Dr. Lozano then completed his Orthopaedic Surgery Residency at New York Medical College in Valhalla, New York. He also completed a fellowship in Orthopaedic Oncology at Massachusetts General Hospital.
- Benign bone tumors
- Benign soft tissue tumors
- Bone cancer
- Bone infections
- Bone metastases
- Limb-sparing procedures
- Malignant bone tumors
- Malignant soft tissue tumors
- Metabolic bone disease
- Metastatic bone disease
- Multiple myeloma
Orthopaedic Oncology Service | Centers for Sarcoma & Chordoma
55 Fruit Street
Yawkey Center for Outpatient Care
Boston, MA 02114
- MD, Pontificia Universidad Javeriana Medical School
- Residency, New York Medical College
- Fellowship, Massachusetts General Hospital*****
American Board Certifications
- Orthopaedic Surgery, American Board of Orthopaedic Surgery
Accepted Insurance Plans
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- Mass General Brigham Health Plan - ACD
- Mass General Brigham Health Plan - PBO
- Medicare - ACD
- Medicare ACO - ACD
- Medicare ACO - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Lozano has a strong interest in clinical research in orthopaedic oncology. His academic practice involves multiple clinical studies evaluating particular neoplastic problems of osseous and connective tissue nature. His focus of research includes clinical outcomes after reconstructive oncologic surgery in the upper and lower extremities, oncologic problems in the upper extremity and functional outcomes after surgical treatment in patients with primary sarcomas of bone and soft-tissue, as well as metastatic bone disease.
In the video below, he discusses the latest innovations in treating bone cancer using patient profiling to develop more targeted treatment plans. You can read more about Dr. Lozano's research on Mass General's Advances in Motion website
- Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Investigators, Ghert M, Schneider P, Guyatt G, Thabane L, V?lez R, O'Shea T, Randall RL, Turcotte R, Wilson D, Wunder JS, Baptista AM, Cheng EY, Doung YC, Ferguson PC, Giglio V, Hayden J, Heels-Ansdell D, Khan SA, Sampath Kumar V, McKay P, Miller B, van de Sande M, Zum?rraga JP, Bhandari M. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial. JAMA Oncol. 2022 Jan 6.
- Melnic CM, Cohen-Levy WB, Lozano-Calderon SA, Heng M. Treatment of Severe Acetabular Bone Loss Using a Tantalum Acetabular Shell and a Cemented Monoblock Dual Mobility Acetabular Cup. J Am Acad Orthop Surg. 2021 Dec 17.
- Groot OQ, Lans A, Twining PK, Bongers MER, Kapoor ND, Verlaan JJ, Newman ET, Raskin KA, Lozano-Calderon SA, Janssen SJ, Schwab JH. Clinical Outcome Differences in the Treatment of Impending Versus Completed Pathological Long-Bone Fractures. J Bone Joint Surg Am. 2021 Nov 30.
- Fourman MS, Ramsey DC, Newman ET, Schwab JH, Chen YL, Hung YP, Chebib I, Deshpande V, Nielsen GP, DeLaney TF, Mullen JT, Raskin KA, Lozano Calder?n SA. Assessing the Safety and Utility of Wound VAC Temporization of the Sarcoma or Benign Aggressive Tumor Bed Until Final Margins Are Achieved. Ann Surg Oncol. 2021 Nov 9. doi: 10.1245/s10434-021-11023-9.
- Kelly SP, Ramkumar DB, Lozano-Calderon SA, Newman ET, Raskin KA, Chebib I, Schwab JH, Peacock ZS. Sclerostin Immunohistochemical Staining in Aggressive Maxillofacial Giant Cell Lesions: Initial Results and Potential Therapeutic Target. J Craniofac Surg. 2021 Nov 9.
- Lunn K, Hoftiezer Y, Lans J, van der Heijden B, Chen N, Lozano-Calder?n SA. Joint-sparing versus nonjoint-sparing reconstruction of the radius following oncologic resection: A systematic review. J Surg Oncol. 2021 Dec;124(8):1523-1535.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, the Cancer Center is among the leading U.S. cancer care providers.
#1 Research Hospital in America
Mass General is the #1 hospital in New England based on U.S. News & World Report Best Hospitals for 2022-2023.
Reviews: Comments and Ratings